GlassScriptPhysician profile
Darron J Molter
NPI 1528105392
$19,869.39
in general payments reported to CMS, 2019-2025
51 companies · $4,560 in 2025
The $4,560 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,174 · 2020: $1,417 · 2021: $2,414 · 2022: $3,394 · 2023: $2,805 · 2024: $3,105 · 2025: $4,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,496 · Consulting Fee: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,495.72 |
| Consulting Fee | $975.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,261.82 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,766.51 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $1,656.86 | 2021-2025 | |
| Amgen INC. | $1,466.60 | 2019-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $1,340.73 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $1,252.51 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $1,011.06 | 2019-2022 | |
| Shionogi INC | $975.00 | 2025 | S-217622 |
| Pfizer INC. | $847.16 | 2019-2025 | |
| Amarin Pharma, INC. | $701.13 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $700.01 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $512.70 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $501.93 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $452.42 | 2019-2024 | Veozah, Myrbetriq |
| Nevro Corp. | $371.42 | 2019-2024 | Senza |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $334.35 | 2022-2025 | Gvoke Hypopen |
| Abbott Laboratories | $329.81 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $284.22 | 2019-2025 | Xifaxan, Trulance |
| Idorsia Pharmaceuticals US INC | $273.16 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $255.87 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $249.83 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $236.23 | 2022-2025 | |
| Dexcom, INC. | $214.30 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Novartis Pharmaceuticals Corporation | $202.07 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $158.28 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $147.53 | 2021 | |
| Biotronik INC. | $137.77 | 2022 | |
| Urovant Sciences INC | $124.65 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $123.59 | 2021 | |
| Daiichi Sankyo INC. | $118.83 | 2023-2024 | Injectafer |
| Boston Scientific Corporation | $95.31 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.75 | 2022-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $87.30 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $81.06 | 2023-2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $73.07 | 2024-2025 | Caplyta |
| Allergan, INC. | $55.22 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.60 | 2020-2022 | |
| Antares Pharma, INC. | $45.22 | 2022 | |
| Esperion Therapeutics, INC. | $40.44 | 2021-2023 | Nexletol |
| Inari Medical, INC. | $37.48 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shield Therapeutics INC | $31.40 | 2024 | |
| Mylan Specialty L.P. | $30.79 | 2022 | |
| Eisai INC. | $26.61 | 2021 | |
| Scilex Pharmaceuticals INC. | $19.72 | 2023 | Ztlido |
| Seqirus USA INC | $18.91 | 2025 | Fluad, Flucelvax |
| Arbor Pharmaceuticals, INC. | $16.47 | 2021 | |
| Hologic Sales and Service, LLC | $16.22 | 2023 | Aptima, Thinprep 2000 Processor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.93 | 2022 | |
| Medtronic Minimed, INC. | $12.50 | 2019 | |
| Strongbridge US INC. | $11.99 | 2020 | |
| Shire North American Group INC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darron Molter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.